Autoantibodies against Type I IFN found to impact morbidity when infected with COVID-19 By Andrew Borgmann Posted April 19, 2022 In Webinar Autoantibodies against Type I IFN found to impact morbidity when infected with COVID-192022-04-192022-06-14/wp-content/uploads/2022/02/canopy-logo-2022-white.pngCanopy Biosciences/wp-content/uploads/2022/02/canopy-logo-2022-white.png200px200px 0 Immunology, NanoString nCounter Andrew Borgmann Recent PostsNew life science startup raises $2 million
